A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
Masonic Cancer Center, University of Minnesota
Northwestern University
Altor BioScience
National Cancer Institute (NCI)